Fairmount Funds Management LLC 13D/13G Filings for Soleno Therapeutics, Inc. (SLNO)

Fairmount Funds Management LLC 13D and 13G filings for Soleno Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-10-10
4:30 pm
Purchase
2023-09-2813GSoleno Therapeutics, Inc.
SLNO
Fairmount Funds Management LLC950,000
6.200%
950,000increase
(New Position)
Filing